Coya Therapeutics (COYA) EPS (Basic) (2022 - 2026)
Coya Therapeutics (COYA) posted EPS (Basic) of -$0.32 for Q1 2026, up 37.85% sequentially from -$0.51 in Q4 2025, and up 27.17% YoY from -$0.25 in Q1 2025.
Coya Therapeutics (COYA) EPS (Basic) (2022 - 2026) Analysis & Trends
Coya Therapeutics has reported EPS (Basic) for 5 years, with the latest figure at -$0.32 in Q1 2026.
- Quarterly EPS (Basic) rose 27.17% year-over-year to -$0.32 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.18 (up 35.86% YoY) and the FY2025 annual result came in at -$1.27, down 30.23% from the prior year.
- EPS (Basic) advanced to -$0.32 in Q1 2026 per COYA's latest filing, from -$0.51 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.19 in Q2 2024 and troughed at -$1.33 in Q2 2022.
- A 5-year average of -$0.57 and a median of -$0.45 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) surged 67.67% in 2023, then tumbled 113.74% in 2024.
- Over 5 years, EPS (Basic) stood at -$1.16 in 2022, then soared by 67.67% to -$0.37 in 2023, then sank by 113.74% to -$0.8 in 2024, then jumped by 36.08% to -$0.51 in 2025, then jumped by 37.85% to -$0.32 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.32, -$0.51, and -$0.29 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.64 Bn | 130.78 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.90 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.11 Bn | 59.93 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 55.83 Bn | 50.69 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.01 Bn | 36.91 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.63 Bn | 28.32 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 27.65 Bn | 9.26 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | 0.18 |
| 10 | Coya Therapeutics | 114.00 Mn | 70.80 Mn | - | -0.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.28 |
| Mar 31, 2026 | -0.32 |
| Dec 31, 2025 | -0.51 |
| Sep 30, 2025 | -0.29 |
| Jun 30, 2025 | -0.36 |
| Mar 31, 2025 | -0.44 |
| Dec 31, 2024 | -0.80 |
| Sep 30, 2024 | -0.55 |
| Jun 30, 2024 | -0.19 |
| Mar 31, 2024 | -0.35 |
| Dec 31, 2023 | -0.37 |
| Sep 30, 2023 | -0.46 |
| Jun 30, 2023 | -0.45 |
| Mar 31, 2023 | -0.41 |
| Dec 31, 2022 | -1.16 |
| Sep 30, 2022 | -1.03 |
| Jun 30, 2022 | -1.33 |
| Mar 31, 2022 | -0.66 |